Ordering
Available Variants5 mg
CHA.50213-5mg
Price
€52.77
Available – Dispatch in 14 days
25 mg
CHA.50213-25mg
Price
€252.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.50213-5mg | €52.77 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.50213-25mg | €252.00 |
≥98%
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C23H29N3O3 |
|---|---|
| CAS Number | 102636-74-8 |
| Molecular Weight | 395.49 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| MDL number | MFCD00288296 |
| Assay | ≥98% |
| Form | powder |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
CINPA1, also known as 2-(4-Chlorophenyl)-N-(2,6-dimethylphenyl)acetamide, is a chemical compound with the CAS number 102636-74-8. This compound has been studied for its potential biological activities, including its effects on various enzymes and receptors. CINPA1 has been shown to exhibit inhibitory activity against certain enzymes, which may contribute to its potential therapeutic applications. Further research is needed to fully understand the mechanisms of action and potential uses of CINPA1. The compounds chemical structure and properties make it an interesting candidate for further investigation, particularly in the fields of pharmacology and medicinal chemistry. Additional studies are required to determine the safety and efficacy of CINPA1 in various contexts, and to explore its potential as a lead compound for the development of new therapeutic agents.
